BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Marimed Inc. MRMD
15 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$159.8M
▲ 1.3% vs FY2024
EPS · FY25
$-0.04
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-9.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 159.8M
Revenue, FY2025 · full 15-year series below
Revenue
Net income
The company lost 9 cents on every revenue dollar this year.
Per share
USD -0.04
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-1.8%
Net margin-9.1%
Return on assets-7.1%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+25.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+6.0%
+25.7%
+62.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.40B
Shares outstanding, FY2025
Change, 5 years+26.2%
Change, 10 years—
The share count grew 26% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 202.6M
total assets, end of FY2025
Total assetsUSD 202.6M
CashUSD 8.9M
Gross debtUSD 76.0M
Net debtUSD 67.2M
Current ratio1.00×
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue $B
0.2
0.2
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
−0.0
·
·
·
·
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
0.0
0.0
0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.04
−0.03
−0.04
0.04
0.02
0.01
−0.39
−0.07
−0.01
−0.00
−0.04
−0.23
−0.02
−0.04
−1.04
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Shares out B
0.40
0.38
0.38
0.34
0.33
0.31
0.23
0.21
0.18
0.06
0.03
0.03
0.03
0.03
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
60 of 60
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed